Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin clearance

Lili Zheng,Junqiu Jia,Yan Chen,Renyuan Liu,Runjing Cao,Manlin Duan,Meijuan Zhang,Yun Xu
DOI: https://doi.org/10.1186/s12974-022-02480-4
IF: 9.3
2022-06-01
Journal of Neuroinflammation
Abstract:Vascular dementia (VAD) is the second most common type of dementia lacking effective treatments. Pentoxifylline (PTX), a nonselective phosphodiesterase inhibitor, displays protective effects in multiple cerebral diseases. In this study, we aimed to investigate the therapeutic effects and potential mechanisms of PTX in VAD.
immunology,neurosciences
What problem does this paper attempt to address?